Cell death at the intestinal epithelial front line

FEBS Journal

Volumn , Issue , 2016, Pages 2701-2719

  Delgado, Maria Eugenia ^a   Grabinger, Thomas ^a   Brunner, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

apoptosis; cell death; chemotherapy; intestinal epithelial cells; irradiation; necroptosis; tumour necrosis factor

Indexed keywords

CADHERIN; CLAUDIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME C; DNA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; PROTEIN BAK; PROTEIN BAX; PROTEIN P53; PUMA PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; BACTERIAL INFECTION; CELL DEATH; CELL FATE; CELL MATURATION; DNA DAMAGE; GENOTOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NECROPTOSIS; NONHUMAN; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SECRETION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TISSUE REGENERATION; VIRUS INFECTION;

EID: 84978943126     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13575     Document Type: Review

References (164)

1. Peppelenbosch MP & van Deventer SJ (2004) T cell apoptosis and inflammatory bowel disease. Gut 53, 1556–1558.
2. Gunther C, Neumann H, Neurath MF & Becker C (2013) Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 62, 1062–1071.
3. Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N & Ruemmele FM (2004) Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 53, 1632–1638.
4. Gao C & Wang AY (2009) Significance of increased apoptosis and Bax expression in human small intestinal adenocarcinoma. J Histochem Cytochem 57, 1139–1148.
5. Watson AJ (2004) Apoptosis and colorectal cancer. Gut 53, 1701–1709.
6. Lockshin RA & Williams CM (1964) Programmed cell death—II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol 10, 643–649.
7. Kerr JF, Wyllie AH & Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239–257.
8. Green DR, Oberst A, Dillon CP, Weinlich R & Salvesen GS (2011) RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 44, 9–16.
9. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19, 107–120.
10. Sakamaki K, Inoue T, Asano M, Sudo K, Kazama H, Sakagami J, Sakata S, Ozaki M, Nakamura S, Toyokuni S et al. (2002) Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ 9, 1196–1206.
11. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O et al. (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267–276.
12. Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G & Pasparakis M (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330–334.
13. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF et al. (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477, 335–339.
14. Tait SW, Ichim G & Green DR (2014) Die another way–non-apoptotic mechanisms of cell death. J Cell Sci 127, 2135–2144.
15. Yuan J & Kroemer G (2010) Alternative cell death mechanisms in development and beyond. Genes Dev 24, 2592–2602.
16. Oberst A & Green DR (2011) It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat Rev Mol Cell Biol 12, 757–763.
17. Piguet PF, Vesin C, Guo J, Donati Y & Barazzone C (1998) TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol 28, 3499–3505.
18. Miron N & Cristea V (2012) Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol 167, 405–412.
19. Kato T & Owen RL (2005) Structure and function of intestinal mucosal epithelium. In Mucosal Immunology, 3rd edn. pp. 131–151. Elsevier Academic Press, Burlington, MA.
20. Gonzalez-Mariscal L, Tapia R & Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778, 729–756.
21. Matter K & Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4, 225–236.
22. Johansson ME, Sjovall H & Hansson GC (2013) The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10, 352–361.
23. Williams JM, Duckworth CA, Burkitt MD, Watson AJ, Campbell BJ & Pritchard DM (2015) Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol 52, 445–455.
24. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, da Xu Z & Deitch EA (2007) Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141, 481–489.
25. Zarepour M, Bhullar K, Montero M, Ma C, Huang T, Velcich A, Xia L & Vallance BA (2013) The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis. Infect Immun 81, 3672–3683.
26. Keshav S, Lawson L, Chung LP, Stein M, Perry VH & Gordon S (1990) Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med 171, 327–332.
27. Gerbe F, Legraverend C & Jay P (2012) The intestinal epithelium tuft cells: specification and function. Cell Mol Life Sci 69, 2907–2917.
28. Brunner T, Arnold D, Wasem C, Herren S & Frutschi C (2001) Regulation of cell death and survival in intestinal intraepithelial lymphocytes. Cell Death Differ 8, 706–714.
29. Cheroutre H, Lambolez F & Mucida D (2011) The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11, 445–456.
30. Haegebarth A & Clevers H (2009) Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174, 715–721.
31. Mayhew TM, Myklebust R, Whybrow A & Jenkins R (1999) Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol Histopathol 14, 257–267.
32. Nunes T, Bernardazzi C & de Souza HS (2014) Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium. Biomed Res Int 2014, 218493.
33. Grossmann J, Maxson JM, Whitacre CM, Orosz DE, Berger NA, Fiocchi C & Levine AD (1998) New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol 153, 53–62.
34. Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M, Pritchard DM, Galle PR, Neurath MF & Watson AJ (2012) Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146–1153.
35. Deinert K, Kiesslich R, Vieth M, Neurath MF & Neuhaus H (2007) In-vivo microvascular imaging of early squamous-cell cancer of the esophagus by confocal laser endomicroscopy. Endoscopy 39, 366–368.
36. Guan Y, Watson AJ, Marchiando AM, Bradford E, Shen L, Turner JR & Montrose MH (2011) Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells. Am J Physiol Cell Physiol 300, C1404–C1414.
37. Watson AJ, Duckworth CA, Guan Y & Montrose MH (2009) Mechanisms of epithelial cell shedding in the Mammalian intestine and maintenance of barrier function. Ann N Y Acad Sci 1165, 135–142.
38. Madara JL (1990) Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 116, 177–184.
39. Watson AJ & Hughes KR (2012) TNF-alpha-induced intestinal epithelial cell shedding: implications for intestinal barrier function. Ann N Y Acad Sci 1258, 1–8.
40. Watson AJ, Chu S, Sieck L, Gerasimenko O, Bullen T, Campbell F, McKenna M, Rose T & Montrose MH (2005) Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 129, 902–912.
41. Beeman N, Webb PG & Baumgartner HK (2012) Occludin is required for apoptosis when claudin-claudin interactions are disrupted. Cell Death Dis 3, e273.
42. Bullen TF, Forrest S, Campbell F, Dodson AR, Hershman MJ, Pritchard DM, Turner JR, Montrose MH & Watson AJ (2006) Characterization of epithelial cell shedding from human small intestine. Lab Invest 86, 1052–1063.
43. Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR & Watson AJ (2011) The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140, 1208–1218, e1–2.
44. Beausejour M, Thibodeau S, Demers MJ, Bouchard V, Gauthier R, Beaulieu JF & Vachon PH (2013) Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of alpha2beta1, alpha3beta1, alpha5beta1, and alpha6beta4 integrins. BMC Cell Biol 14, 53.
45. Levine AD (2000) Apoptosis: implications for inflammatory bowel disease. Inflamm Bowel Dis 6, 191–205.
46. Grabinger T, Luks L, Kostadinova F, Zimberlin C, Medema JP, Leist M & Brunner T (2014) Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Cell Death Dis 5, e1228.
47. Paoli P, Giannoni E & Chiarugi P (2013) Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 1833, 3481–3498.
48. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, Huang DC & Strasser A (2001) Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293, 1829–1832.
49. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK & Brugge JS (2003) Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5, 733–740.
50. Piguet PF, Vesin C, Donati Y & Barazzone C (1999) TNF-induced enterocyte apoptosis and detachment in mice: induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk. Lab Invest 79, 495–500.
51. Chowdhury I, Tharakan B & Bhat GK (2008) Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol 151, 10–27.
52. Schneider-Jakob S, Corazza N, Badmann A, Sidler D, Stuber-Roos R, Keogh A, Frese S, Tschan M & Brunner T (2010) Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell Death Dis 1, e86.
53. Tang Y, Swartz-Basile DA, Swietlicki EA, Yi L, Rubin DC & Levin MS (2004) Bax is required for resection-induced changes in apoptosis, proliferation, and members of the extrinsic cell death pathways. Gastroenterology 126, 220–230.
54. Youle RJ & Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59.
55. Kelekar A & Thompson CB (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol 8, 324–330.
56. Lindsay J, Esposti MD & Gilmore AP (2011) Bcl-2 proteins and mitochondria–specificity in membrane targeting for death. Biochim Biophys Acta 1813, 532–539.
57. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Nakayama K & Hickman JA (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108 (Pt 6), 2261–2271.
58. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T & Korsmeyer SJ (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135–139.
59. Hausmann M, Leucht K, Ploner C, Kiessling S, Villunger A, Becker H, Hofmann C, Falk W, Krebs M, Kellermeier S et al. (2011) BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem 286, 26533–26540.
60. Rosen K, Rak J, Leung T, Dean NM, Kerbel RS & Filmus J (2000) Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol 149, 447–456.
61. Haraguchi M, Torii S, Matsuzawa S, Xie Z, Kitada S, Krajewski S, Yoshida H, Mak TW & Reed JC (2000) Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J Exp Med 191, 1709–1720.
62. Bratton SB & Salvesen GS (2010) Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 123, 3209–3214.
63. Kim HE, Du F, Fang M & Wang X (2005) Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci USA 102, 17545–17550.
64. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES & Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489.
65. Pop C, Timmer J, Sperandio S & Salvesen GS (2006) The apoptosome activates caspase-9 by dimerization. Mol Cell 22, 269–275.
66. Aoudjit F & Vuori K (2001) Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol 152, 633–643.
67. Rytomaa M, Martins LM & Downward J (1999) Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr Biol 9, 1043–1046.
68. French LE & Tschopp J (2003) Protein-based therapeutic approaches targeting death receptors. Cell Death Differ 10, 117–123.
69. Lavrik I, Golks A & Krammer PH (2005) Death receptor signaling. J Cell Sci 118, 265–267.
70. Ashkenazi A & Dixit VM (1998) Death receptors: signaling and modulation. Science 281, 1305–1308.
71. Lavrik IN & Krammer PH (2012) Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 19, 36–41.
72. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3, 745–756.
73. Siegel RM, Martin DA, Zheng L, Ng SY, Bertin J, Cohen J & Lenardo MJ (1998) Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol 141, 1243–1253.
74. Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L, Schwabe JW, Cain K & Macfarlane M (2012) A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 47, 291–305.
75. Schleich K, Warnken U, Fricker N, Ozturk S, Richter P, Kammerer K, Schnolzer M, Krammer PH & Lavrik IN (2012) Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell 47, 306–319.
76. Budd RC, Yeh WC & Tschopp J (2006) cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 6, 196–204.
77. Piao X, Komazawa-Sakon S, Nishina T, Koike M, Piao JH, Ehlken H, Kurihara H, Hara M, Van Rooijen N, Schutz G et al. (2012) c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci Signal 5, ra93.
78. Seidelin JB, Coskun M, Vainer B, Riis L, Soendergaard C & Nielsen OH (2013) ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis. J Mol Med (Berl) 91, 839–849.
79. Slebioda TJ & Kmiec Z (2014) Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2014, 325129.
80. Bamias G, Kaltsa G, Siakavellas SI, Gizis M, Margantinis G, Zampeli E, Vafiadis-Zoumboulis I, Michopoulos S, Daikos GL & Ladas SD (2012) Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. Dig Liver Dis 44, 30–36.
81. Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, Gdynia G, Li L, Gretz N, Macher-Goeppinger S et al. (2009) Functional characterisation of decoy receptor 3 in Crohn's disease. Gut 58, 483–491.
82. Luthi AU & Martin SJ (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ 14, 641–650.
83. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C & Martin SJ (2008) Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 105, 12815–12819.
84. Hunter AM, LaCasse EC & Korneluk RG (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12, 1543–1568.
85. Eckelman BP & Salvesen GS (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281, 3254–3260.
86. Liu Z, Li H, Wu X, Yoo BH, Yan SR, Stadnyk AW, Sasazuki T, Shirasawa S, LaCasse EC, Korneluk RG et al. (2006) Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells. Oncogene 25, 7680–7690.
87. Yoo BH, Berezkin A, Wang Y, Zagryazhskaya A & Rosen KV (2012) Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells. Int J Cancer 131, 357–366.
88. Croitoru K & Zhou P (2004) T-cell-induced mucosal damage in the intestine. Curr Opin Gastroenterol 20, 581–586.
89. Lin T, Brunner T, Tietz B, Madsen J, Bonfoco E, Reaves M, Huflejt M & Green DR (1998) Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. J Clin Invest 101, 570–577.
90. Offit PA, Cunningham SL & Dudzik KI (1991) Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol 65, 1318–1324.
91. Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14, 329–342.
92. Noth R, Stuber E, Hasler R, Nikolaus S, Kuhbacher T, Hampe J, Bewig B, Schreiber S & Arlt A (2012) Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn's disease. J Crohns Colitis 6, 464–469.
93. Moore JV (1986) The ‘gastrointestinal syndrome’ after chemotherapy: inferences from mouse survival time, and from histologically- and clonogenically-defined cell death in intestinal crypts. Br J Cancer Suppl 7, 16–19.
94. Jin S (2012) Role of p53 in anticancer drug treatment- and radiation-induced injury in normal small intestine. Cancer Biol Med 9, 1–8.
95. Xian CJ (2003) Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair. Curr Pharm Biotechnol 4, 260–269.
96. Branzei D & Foiani M (2008) Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 9, 297–308.
97. Bartek J & Lukas J (2007) DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 19, 238–245.
98. Meek DW (2009) Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9, 714–723.
99. Riley T, Sontag E, Chen P & Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9, 402–412.
100. Clarke AR, Gledhill S, Hooper ML, Bird CC & Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9, 1767–1773.
101. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP & Hall PA (1994) The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 54, 614–617.
102. Nakano K & Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7, 683–694.
103. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T & Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053–1058.
104. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A & Villunger A (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106, 4131–4138.
105. Miyashita T & Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293–299.
106. Pietrzak M & Puzianowska-Kuznicka M (2008) p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol Chem 389, 383–393.
107. Hill R, Madureira PA, Waisman DM & Lee PW (2011) DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget 2, 1094–1108.
108. Michalak EM, Villunger A, Adams JM & Strasser A (2008) In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15, 1019–1029.
109. Dirisina R, Katzman RB, Goretsky T, Managlia E, Mittal N, Williams DB, Qiu W, Yu J, Chandel NS, Zhang L et al. (2011) p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis. Gastroenterology 141, 1036–1045.
110. Qiu W, Wu B, Wang X, Buchanan ME, Regueiro MD, Hartman DJ, Schoen RE, Yu J & Zhang L (2011) PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest 121, 1722–1732.
111. Hock AK & Vousden KH (2012) Tumor suppression by p53: fall of the triumvirate? Cell 149, 1183–1185.
112. Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, Posca D, Ryu H, Katzman RB & Barrett TA (2012) p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J Pathol 181, 1306–1315.
113. Merritt AJ, Allen TD, Potten CS & Hickman JA (1997) Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14, 2759–2766.
114. Roos WP & Kaina B (2006) DNA damage-induced cell death by apoptosis. Trends Mol Med 12, 440–450.
115. Komarova EA, Kondratov RV, Wang K, Christov K, Golovkina TV, Goldblum JR & Gudkov AV (2004) Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene 23, 3265–3271.
116. Husain KD & Coopersmith CM (2003) Role of intestinal epithelial apoptosis in survival. Curr Opin Crit Care 9, 159–163.
117. Chopra M, Brandl A, Siegmund D, Mottok A, Schafer V, Biehl M, Kraus S, Bauerlein CA, Ritz M, Mattenheimer K et al. (2015) Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GvHD. Blood 126, 437–444.
118. Merger M, Viney JL, Borojevic R, Steele-Norwood D, Zhou P, Clark DA, Riddell R, Maric R, Podack ER & Croitoru K (2002) Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut 51, 155–163.
119. Wasem C, Frutschi C, Arnold D, Vallan C, Lin T, Green DR, Mueller C & Brunner T (2001) Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease. J Immunol 167, 2936–2941.
120. Xiao S, Sung SS, Fu SM & Ju ST (2003) Combining Fas mutation with interleukin-2 deficiency prevents Colitis and Lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death. J Biol Chem 278, 52730–52738.
121. Park SM, Chen L, Zhang M, Ashton-Rickardt P, Turner JR & Peter ME (2010) CD95 is cytoprotective for intestinal epithelial cells in colitis. Inflamm Bowel Dis 16, 1063–1070.
122. Cullen SP & Martin SJ (2015) Fas and TRAIL ‘death receptors’ as initiators of inflammation: implications for cancer. Semin Cell Dev Biol 39, 26–34.
123. Pinkoski MJ, Droin NM, Lin T, Genestier L, Ferguson TA & Green DR (2002) Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion. Proc Natl Acad Sci USA 99, 16174–16179.
124. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5, 157–163.
125. Ashkenazi A & Herbst RS (2008) To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118, 1979–1990.
126. von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L et al. (2015) Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell 27, 561–573.
127. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P et al. (2006) TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 116, 2493–2499.
128. Corazza N, Kassahn D, Jakob S, Badmann A & Brunner T (2009) TRAIL-induced apoptosis: between tumor therapy and immunopathology. Ann N Y Acad Sci 1171, 50–58.
129. Strater J, Walczak H, Pukrop T, Von Muller L, Hasel C, Kornmann M, Mertens T & Moller P (2002) TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology 122, 659–666.
130. Brost S, Koschny R, Sykora J, Stremmel W, Lasitschka F, Walczak H & Ganten TM (2010) Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathol Res Pract 206, 43–50.
131. Kaufmann T, Jost PJ, Pellegrini M, Puthalakath H, Gugasyan R, Gerondakis S, Cretney E, Smyth MJ, Silke J, Hakem R et al. (2009) Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30, 56–66.
132. Wang K, Han G, Dou Y, Wang Y, Liu G, Wang R, Xiao H, Li X, Hou C, Shen B et al. (2012) Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice. PLoS One 7, e52924.
133. Corazza N, Eichenberger S, Eugster HP & Mueller C (1999) Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J Exp Med 190, 1479–1492.
134. Wirtz S & Neurath MF (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59, 1073–1083.
135. Suzuki T (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70, 631–659.
136. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D et al. (2004) Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21, 415–428.
137. Wang L, Du F & Wang X (2008) TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693–703.
138. Micheau O & Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190.
139. Sun C, Cai M, Gunasekera AH, Meadows RP, Wang H, Chen J, Zhang H, Wu W, Xu N, Ng SC et al. (1999) NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 401, 818–822.
140. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T et al. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36, 831–844.
141. Varfolomeev EE & Ashkenazi A (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491–497.
142. Guma M, Stepniak D, Shaked H, Spehlmann ME, Shenouda S, Cheroutre H, Vicente-Suarez I, Eckmann L, Kagnoff MF & Karin M (2011) Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208, 1889–1900.
143. Karrasch T, Steinbrecher KA, Allard B, Baldwin AS & Jobin C (2006) Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J Cell Physiol 207, 809–815.
144. Hehlgans T & Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115, 1–20.
145. Roulis M, Armaka M, Manoloukos M, Apostolaki M & Kollias G (2011) Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology. Proc Natl Acad Sci USA 108, 5396–5401.
146. Seidelin JB, Vainer B, Andresen L & Nielsen OH (2007) Upregulation of cIAP2 in regenerating colonocytes in ulcerative colitis. Virchows Arch 451, 1031–1038.
147. Lavrik IN, Mock T, Golks A, Hoffmann JC, Baumann S & Krammer PH (2008) CD95 stimulation results in the formation of a novel death effector domain protein-containing complex. J Biol Chem 283, 26401–26408.
148. Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK et al. (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 182, 171–184.
149. Wicovsky A, Salzmann S, Roos C, Ehrenschwender M, Rosenthal T, Siegmund D, Henkler F, Gohlke F, Kneitz C & Wajant H (2009) TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling. Cell Death Differ 16, 1445–1459.
150. Vandenabeele P, Galluzzi L, Vanden Berghe T & Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11, 700–714.
151. Christofferson DE & Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22, 263–268.
152. Galluzzi L, Kepp O & Kroemer G (2009) RIP kinases initiate programmed necrosis. J Mol Cell Biol 1, 8–10.
153. Sun X, Yin J, Starovasnik MA, Fairbrother WJ & Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277, 9505–9511.
154. Vandenabeele P, Declercq W, Van Herreweghe F & Vanden Berghe T (2010) The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 3, re4.
155. Micheau O, Lens S, Gaide O, Alevizopoulos K & Tschopp J (2001) NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21, 5299–5305.
156. Fricker N, Beaudouin J, Richter P, Eils R, Krammer PH & Lavrik IN (2010) Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol 190, 377–389.
157. Krueger A, Schmitz I, Baumann S, Krammer PH & Kirchhoff S (2001) Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276, 20633–20640.
158. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC & Karin M (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124, 601–613.
159. Han J, Zhong CQ & Zhang DW (2011) Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12, 1143–1149.
160. Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Goncalves A, Sze M, Gilbert B, Kourula S et al. (2014) RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95–99.
161. Wine E (2014) Should we be treating the bugs instead of cytokines and T cells? Dig Dis 32, 403–409.
162. Martinon F, Gaide O, Petrilli V, Mayor A & Tschopp J (2007) NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29, 213–229.
163. Mocarski ES, Upton JW & Kaiser WJ (2012) Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 12, 79–88.
164. Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10, 131–144.